ERIN HARRELL: Open Payments
NPI 1376066688 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 47 payments from 13 companies in 2025. Trend: 2023 $590 · 2024 $701 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $150 |
| SCPHARMACEUTICALS INC. | 5 | $104 |
| Medtronic, Inc. | 1 | $101 |
| E.R. Squibb & Sons, L.L.C. | 6 | $100 |
| PFIZER INC. | 5 | $95 |
| Merck Sharp & Dohme LLC | 6 | $87 |
| Philips North America LLC | 3 | $60 |
| Alnylam Pharmaceuticals Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
Products named: LEQVIO, FUROSCIX, SYMPLICITY G3, CAMZYOS, VERQUVO, Ambulatory Monitoring & Diagnostics Undivided, ELIQUIS, AMVUTTRA.
Industry payments across AL — which companies pay providers there.
